Hims & Hers Health stock outlook: Upside likely as momentum improves and buyers dominate

Traders Union
All News
Stocks
Hims & Hers Health up 3.82% today

Highlights

Hims & Hers Health expanded into Germany with an online weight management service for men, offering prescription GLP-1 therapies through a partnership with Novo Nordisk.
The service operates via its acquired Zava digital health platform, enabling streamlined online consultations and access to EU-licensed clinicians for German patients.
Shares of Hims & Hers Health show sustained bullish momentum, with price expected to range between $27.6 and $30.82 in the next 2 to 3 days and upside probability categorized as very high.

German expansion and Novo Nordisk partnership accelerate digital platform adoption

Hims & Hers Health has launched an online weight management service for men in Germany, significantly expanding its presence in one of Europe's largest healthcare markets, according to Yahoo Finance. The new service leverages its acquisition of the digital health platform Zava to streamline operations and offers prescription GLP-1 weight loss medications through a partnership with Novo Nordisk, as reported by Gurufocus. German patients can now complete online consultations and, if eligible, receive prescription therapies from EU-licensed clinicians, further enhancing patient accessibility and driving increased adoption of Hims & Hers Health's digital offerings.

Sustained bullish bias as support holds and momentum builds

Technically, HIMS is trading above its MA-20 at $28.73, MA-50 at $29.05, and MA-200 at $27.22, pointing to prevailing upside momentum on all time frames. The Ichimoku Kijun at $28.42 acts as immediate support for current price action. A MACD Buy signal and neutral ADX suggest momentum is building, though not yet forceful, while an RSI reading of 54.3 and CCI both flag mildly bullish conditions. Stoch RSI is neutral, but Bull/Bear Power shows buyers are dominating intraday, and the Awesome Oscillator confirms the upward trend. Intraday volatility remains high with the price positioning near the mid-range following a modest gap down on open and sustained buyer interest.

Bullish breakout likely as volatility lifts upside potential

Over the next 2–3 trading days, HIMS is expected to trade within a $27.6 to $30.82 band, consistent with its recent volatility. Further upside is deemed very likely, while downside risk appears limited under prevailing momentum. The base case is for continued sideways action, but a bullish breakout above $30.82 would signal a renewed upward leg. Conversely, a break below $27.6 would point to a short-term retracement scenario.

Viktoras Karapetjanc, analyst at Traders Union, sees Hims & Hers Health's expansion into Germany as a strong signal of strategic growth. He believes the integration of digital service delivery and new partnerships solidifies the company’s fundamentals in a major European market. Technical indicators show upside momentum and bullish sentiment persists. "The combination of innovation, market entry, and strong price action supports a constructive outlook for HIMS in the near term."

Previously it was reported that Hims & Hers Health faced heightened legal and regulatory risk, with technicals indicating persistent selling pressure. The current advance above key moving averages, driven by the expansion into Germany's weight management market, adds a new dimension and puts the $30.82 breakout level in focus as a potential trigger for further upside.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.